Publikationen (63) Publikationen, an denen Forscher/innen teilgenommen haben

2012

  1. A framework for simplifying educator tasks related to the integration of games in the learning flow

    Educational Technology and Society, Vol. 15, Núm. 4, pp. 305-318

  2. A narrative metaphor to facilitate educational game authoring

    Computers and Education, Vol. 58, Núm. 1, pp. 590-599

  3. Antiretroviral drugs for pre-exposure prophylaxis of HIV infection

    AIDS Reviews, Vol. 14, Núm. 1, pp. 54-61

  4. Antiviral effect of raltegravir on HTLV-1 carriers

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 1, pp. 218-221

  5. Análisis de aplicabilidad de los mecanismos de flexibilidad del protocolo de Kioto para el control del cambio climático

    Sociedad y utopía: Revista de ciencias sociales, Núm. 40, pp. 86-99

  6. Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 6, pp. 2873-2878

  7. Caso Repsol Portuguesa: Cómo vencer la resistencia al cambio

    Harvard Deusto business review, Núm. 212, pp. 38-47

  8. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  9. Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay

    Journal of Clinical Microbiology, Vol. 50, Núm. 3, pp. 569-572

  10. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial

    Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968

  11. Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms

    Clinical Infectious Diseases, Vol. 55, Núm. 1

  12. Differences in virological response to peginterferon-a plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1b

    Journal of Acquired Immune Deficiency Syndromes, Vol. 60, Núm. 2, pp. 117-123

  13. Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

    Journal of Clinical Virology, Vol. 55, Núm. 1, pp. 58-61

  14. Drug resistance testing in hepatitis C therapy

    Future Virology, Vol. 7, Núm. 3, pp. 309-321

  15. Dynamic, ecological, accessible and 3D virtual Worlds-based libraries using OpenSIm and Sloodle along with mobile location and NFC for checking in

    IJIMAI, Vol. 1, Núm. 7, pp. 63-69

  16. E-UCM (Grupo de Investigación en e-learning), UCM

    IE Comunicaciones: Revista Iberoamericana de Informática Educativa, Núm. 15, pp. 37-46

  17. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the phase III randomized, double-blind ECHO and THRIVE trials

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 8, pp. 2020-2028

  18. El modelo líder líder: Parte 1

    Observatorio de recursos humanos y relaciones laborales, Núm. 69, pp. 58-62

  19. El modelo líder líder: Parte 2

    Observatorio de recursos humanos y relaciones laborales, Núm. 70, pp. 53-58

  20. Emerging viral infections - A potential threat for blood supply in the 21st century

    AIDS Reviews, Vol. 14, Núm. 4, pp. 279-289